<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Mitoception Via the Metabokine GDF15 And Human Health</title>
				<funder>
					<orgName type="full">Wharton Fund</orgName>
				</funder>
				<funder ref="#_sN6Y68s #_4WCadsx #_xuaRQSZ #_UjVaDay">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder ref="#_6ATzYVJ #_yj2dCb7">
					<orgName type="full">Baszucki Brain Research Fund</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Cynthia</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Division of Behavioral Medicine</orgName>
								<orgName type="institution">Columbia University Irving Medical Center</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Qiuhan</forename><surname>Huang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Division of Behavioral Medicine</orgName>
								<orgName type="institution">Columbia University Irving Medical Center</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Evan</forename><forename type="middle">D</forename><surname>Shaulson</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Division of Behavioral Medicine</orgName>
								<orgName type="institution">Columbia University Irving Medical Center</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Caroline</forename><surname>Trumpff</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Division of Behavioral Medicine</orgName>
								<orgName type="institution">Columbia University Irving Medical Center</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elissa</forename><surname>Epel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Psychiatry and Behavioral Sciences</orgName>
								<orgName type="institution">University of California San Francisco</orgName>
								<address>
									<postCode>94143</postCode>
									<settlement>San Francisco</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lisa</forename><forename type="middle">Feldman</forename><surname>Barrett</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">Northeastern University</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country>USA;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><forename type="middle">W</forename><surname>Belsky</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Columbia University Mailman School of Public Health</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Robert N Butler Columbia Aging Center</orgName>
								<orgName type="department" key="dep2">Mailman School of Public Health</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maxwell</forename><forename type="middle">Z</forename><surname>Wilson</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Molecular, Cellular, and Developmental Biology</orgName>
								<orgName type="institution">University of California Santa Barbara</orgName>
								<address>
									<postCode>93106</postCode>
									<settlement>Santa Barbara</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alan</forename><forename type="middle">A</forename><surname>Cohen</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Robert N Butler Columbia Aging Center</orgName>
								<orgName type="department" key="dep2">Mailman School of Public Health</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tor</forename><forename type="middle">D</forename><surname>Wager</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Psychological and Brain Sciences</orgName>
								<orgName type="institution">Dartmouth College</orgName>
								<address>
									<postCode>03755</postCode>
									<settlement>Hanover</settlement>
									<region>NH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Martin</forename><surname>Picard</surname></persName>
							<email>martin.picard@columbia.edu</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Division of Behavioral Medicine</orgName>
								<orgName type="institution">Columbia University Irving Medical Center</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Robert N Butler Columbia Aging Center</orgName>
								<orgName type="department" key="dep2">Mailman School of Public Health</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Neurology</orgName>
								<orgName type="department" key="dep2">H. Houston Merritt Center</orgName>
								<orgName type="institution">Columbia University Irving Medical Center</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">New York State Psychiatric Institute</orgName>
								<address>
									<postCode>10032</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Psychiatry</orgName>
								<orgName type="department" key="dep2">Athinoula A. Martinos Center for Biomedical Imaging</orgName>
								<orgName type="institution">the Massachusetts General Hospital</orgName>
								<address>
									<postCode>02129</postCode>
									<settlement>Charlestown</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Mitoception Via the Metabokine GDF15 And Human Health</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">60502FE98D5619E98C48E49B927B7459</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-10-22T20:20+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>metaboception</term>
					<term>bioenergetics</term>
					<term>mitoception</term>
					<term>GDF15</term>
					<term>energetic pain</term>
					<term>fatigue</term>
					<term>anxiety</term>
					<term>behaviors</term>
					<term>stress-disease cascade</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>To survive and thrive, living organisms must monitor and regulate cell-level energy supply, demand, and transformation. They do so through a brain-directed interoceptive process we refer to as "metaboception." Here, we describe a specific metaboceptive signaling cascade mediated by the metabokine/cytokine growth differentiation factor 15 (GDF15), which we name "mitoception." Mitoception involves an afferent signaling arm initiated by the integrative stress response (ISR), and an efferent signaling arm that simultaneously promotes energy conservation and fuel mobilization. Afferent mitoceptive signaling is mediated by GDF15 released when cells face energy demand in excess of their energy transformation capacity, creating an "energy gap". Efferent mitoceptive signaling arises when GDF15 receptors in the brainstem receive the signal and initiate psychological experiences including fatigue and anxiety, together with neuroendocrine stress responses. Mitoceptive outputs thus reprioritize systemic energy metabolism to promote allostasis, survival, and long-term health. The proposed GDF15-driven mitoception cascade makes predictions about modifiable processes that shape disease risk, mental health, mood, resilience, well-being, and aging.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>To coordinate the symphony of physiological systems and activities that keep us alive, physiologically regulated, and thriving, the brain relies on interoceptive signals, such as those of nociception 1,2 and immunoception <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> . Sensory signals arise from almost all tissues of the body, enabling animal brains to perceive and precisely locate threats to physical integrity such as pressure, heat, and tissue damage. Nociceptive signals are hard to ignore -directing attention and actions towards those that promote survival. Similarly, the activated immune system uses cytokines to "subjugate the brain" and produce optimal healing conditions and behaviors <ref type="bibr" target="#b4">5</ref> . A general capacity for interoception -the brain's modeling of the internal state of the body <ref type="bibr" target="#b5">6</ref> -is key to health.</p><p>The most vital element of life is the flow of energy <ref type="bibr" target="#b6">7</ref> . Without energy transformation, cellular and organismal life ends. In the same way that the brain constantly integrates afferent signals to coordinate the visceral organs, movements, and the features of lived experience to avoid physical injury, the brain must also constantly monitor the body's energetic state via interoceptive signaling. This is accomplished by what we term metaboception: the brain's bidirectional monitoring and control of energy supply, demand, and transformation capacity. Metaboception involves a neuroanatomically distributed set of key brain areas and circuitry, especially the brainstem, hypothalamus, and hippocampus <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref> , as well as peripheral afferent peptidergic and metabolite signals from canonical "metabolic organs" that either supply energy (stomach, intestines) <ref type="bibr" target="#b9">10</ref> , store energy (adipose, liver) <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref> , transform energy (liver) <ref type="bibr" target="#b12">13</ref> , and exhibit large fluctuations in energy consumption (skeletal muscles, immune system) 5, <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> which have been extensively reviewed elsewhere (Box 1).</p><p>The less well-defined arm of metaboception relates to mechanisms that inform the brain of mismatch between energy demand and energy transformation capacity. If the rates of energy demand and the transformation capacity are properly matched, the organism can sustainably and efficiently fuel its operations through mitochondrial oxidative phosphorylation (OxPhos, converting food and oxygen into ATP). But if a mismatch arises between energy expenditure (e.g., excessive demand, arising from sickness or exhaustive exercise for example) relative to energy transformation capacity (e.g., limited mitochondrial OxPhos capacity), this creates an energy gap.</p><p>Energy gaps are direct threats to survival because organisms have access only to a finite energy budget and are thus energetically constrained <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref> . So how are energy gaps sensed? Is the energy gap computed from multiple signals in the brain or locally in peripheral cells? The first third of this article covers the biology of GDF15, the second third discusses psychobiological processes underlying its regulation and link with the mind, and the last third covers downstream effects of GDF15 signaling and its health implications.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Origin of energy gaps in mitochondria</head><p>To avoid persistent energy gaps, which may culminate in the deadly possibility of running out of energy, animals evolved multiple redundant pathways to sense energy gaps. Energy gaps can arise from two main sources <ref type="bibr" target="#b13">14</ref> . One source is excess energy demand, which increases when normal yet costly cellular processes are activated, such as immune cell activation, contraction, protein synthesis, and from so called "stress responses" that cost energy and therefore drive hypermetabolism <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref> . A second source is impaired energy transformation capacity, which can result from inherited or acquired deficits in mitochondrial OxPhos capacity, or hypoxia, which restrict electron flow through the mitochondrial electron transport chain, ultimately reducing maximal ATP synthesis capacity <ref type="bibr" target="#b23">24</ref> . Excess energy demand and reduced OxPhos capacity can also combine, as is the case in mitochondrial diseases <ref type="bibr" target="#b24">25</ref> and aging/frailty <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref> , further widening the gap between the rate of demand and what can be sustainably met.</p><p>As a form of distributed peripheral computation, the energy gap is then detected directly in each mitochondrion, or rather, in the distributed Mitochondrial Information Processing System (MIPS) together with other organelles including the nucleus <ref type="bibr" target="#b27">28</ref> . Several mechanisms allow mitochondria to signal their functional states to the nucleus via "retrograde" signalling <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> , and then systemically via secreted proteins, metabolites, cell-free DNA, and possibly whole mitochondria <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref> . Many of these signals are understood to represent general signals of impaired mitochondrial biology. However, they may in fact represent specialized metaboceptive signals informing the brain of the energetic state of its mitochondria. We term the processing of this signal mitoception: the brain's monitoring of the balance between cellular energy demand and mitochondrial energy transformation capacity. An active challenge for the field lies in identifying the trigger(s) and purpose(s) for specific mitochondria-derived signals conveying information from organelle-to-brain.</p><p>Recent evidence in molecular and cell biology, as well as in clinical and epidemiology suggests a key mitoceptive signal: the cytokine/metabokine Growth Differentiation Factor 15 (GDF15) <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35</ref> . Across fields, GDF15 was independently discovered as a biomarker of aging that increases exponentially with age <ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref> , the top protein biomarker for dozens of current and future diseases <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40</ref> , the cause of morning sickness during pregnancy <ref type="bibr" target="#b40">41</ref> , and a driver of cancer-related cachexia <ref type="bibr" target="#b41">42</ref> . Physiologically, GDF15 is also elevated acutely during strenuous exercise (e.g., marathon running) <ref type="bibr" target="#b42">43</ref> , but baseline circulating GDF15 is lower in regular exercisers who have higher mitochondrial OxPhos capacity conferred by increased mitochondrial biogenesis <ref type="bibr" target="#b43">44</ref> . Clinically, GDF15 is also the top protein biomarker of primary mitochondrial diseases <ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref> , where genetic mitochondrial defects directly widen the cellular energy gap.</p><p>Our proposal is that GDF15 is a mitoceptive signal reflecting energy gaps. This body-tobrain signaling pathway resolves GDF15's status as pan-disease marker, and reveals how psychobiological risk and resilience factors may converge, and in fact be integrated through energy, to shape human experiences and health trajectories.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cellular metaboceptors and the body-to-brain axis</head><p>Cells operate as computing agents <ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref> , constantly integrating their internal state and external signals to guide their behaviors and tune their physiology. A first cue into the purpose of the GDF15-based body-to-brain mitoceptive axis of communication is supported by the crosstissue distribution pattern of GDF15 and its receptor.</p><p>The gene GDF15 is expressed across nearly all organs and tissues of the human body, although expression levels are particularly low in the brain. In bulk RNA sequencing data from 948 individuals, baseline brain GDF15 expression is ~300-fold lower than in the kidneys (highest) (Figure <ref type="figure">1A</ref>). However, it is possible that acute injury may induce GDF15 in the brain <ref type="bibr" target="#b50">51</ref> .</p><p>On the other and, the only well-defined GDF15 receptor to date, GDNF family receptor α-like (GFRAL), is expressed in only one anatomically restricted region of the medullary brainstem including the area postrema and immediately adjoining medial nucleus of the solitary tract (NTS) <ref type="bibr" target="#b51">52</ref> , both of which contains GFRAL-positive neurons <ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref> (Figure <ref type="figure">1A</ref>). While the NTS receives ascending interoceptive signals directly from the nodose ganglia of the vagus nerve, the area postrema acts as a "circumventricular organ" by virtue of being highly vascularized by fenestrated capillaries. Pores between the vasculature and the area postrema allow relatively free passage of large macromolecules (e.g., proteins and peptide hormones) into the brain that would otherwise remain segregated from the brain via the blood brain barrier <ref type="bibr" target="#b57">58,</ref><ref type="bibr" target="#b58">59</ref> . This mutually exclusive body-brain distribution pattern for the GDF15-GFRAL signal-to-receptor system provides a remarkable example of a body-to-brain afferent axis of metaboception.</p><p>Just as the brain computes a global, systemic summary of the organism's current and future energetic state in the context of metaboception construed broadly, we propose that cells and their MIPS locally compute their current and anticipated (likely short-term) energetic state in the context of mitoception. Each cell-mitochondria unit then emerges as a metaboceptor: an energetic sensor unit that locally computes the energy gap and relays that information to the brain. As reviewed below, the major signaling cytokine used to signal a cell's energy gap to the rest of the organism is GDF15 <ref type="bibr" target="#b59">60</ref> .</p><p>The expression pattern for GDF15 reveals that among high expressing organs, only specific cell types exhibit high GDF15 RNA and protein levels (Figure <ref type="figure">1B</ref>, additional organs in Supplemental Figure <ref type="figure">S1</ref>) <ref type="bibr" target="#b60">61</ref> . For example, in the kidneys, only the proximal tubule cells express GDF15, whereas cells of the glomerulus are negative for the GDF15 protein. Similarly, in the pancreas, GDF15 was only expressed in the acinar cells, and not in islet cells. Thus, specialized cell types in various organs, largely but not exclusively secretory cell types, appear to act as dedicated metaboceptors capable of alerting the brain of the energy gap at a specific point in time. This cell specificity calls for more spatially and temporally resolved studies to examine local cellular metaboception and mitoception mechanisms that initiate the afferent arm of organismal mitoception.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 1. The GDF15-GFRAL body-brain axis. (A)</head><p>The GDF15 gene is expressed in all human tissues, except the brain 61 (left, tissues ranked by GDF15 expression level). Some brain regions show trace GDF15 expression but represent &lt;1% of the median of other somatic tissues. In contrast, although GFRAL may be expressed at some levels in some non-brain mouse tissues, GFRAL is expressed only in the human brain, and not in any appreciable levels in any of the dozens of other somatic tissues examined 53 (right). In the GTEx dataset <ref type="bibr" target="#b61">62</ref> , GFRAL exhibits trace expression (mRNA levels &lt; 1 normalized transcript per million, nTPM) in adipose tissue, testes, and breast tissue, but the protein is not detected in these tissues (right, tissues in same order as for GDF15 expression panel). Note that the medullary brainstem including the area postrema and nucleus of the solitary tract (NTS), which contain GFRAL + neurons, are absent from this dataset. Thus, this polarized distribution illustrates a body-to-brain mitoception signaling axis where GDF15 made by peripheral metaboceptors directly signals onto the brain, as previously discussed 34 . (B) Immunolabeling of GDF15 in human tissue sections from selected organs showing cell-type specific expression and regional heterogeneity in GDF15 protein abundance in the kidney and pancreas. Images from other organs are available in Supplemental Figure <ref type="figure">1</ref>. The inset shows GDF15 RNA transcript levels from single cell RNA sequencing in each tissue from the Human Protein Atlas <ref type="bibr" target="#b62">63</ref> . GDF15 expression is averaged by major cell types.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Part 1 -AFFERENT ARM OF MITOCEPTION</head><p>In the following sections, we review the afferent arm of GDF15-based mitoception. We begin with the molecular and cellular processes that frame cells as metaboceptors capable of releasing GDF15 into the circulation. Next, we review the concept of reductive stress <ref type="bibr" target="#b63">64</ref> as the trigger for the integrated stress response (ISR), the gene program that triggers GDF15. We show how GDF15 is also a primary biomarker of mitochondrial defects as well as other chronic illnesses, which together point to energy gaps as the common features of many disease states. We close this section by discussing how GDF15 is acutely inducible by mental stress, and how it is generally elevated in response to chronic psychosocial stressors, adversity and psychiatric disorders, pointing to the psychobiological convergence of psychosocial and biological stressors through mechanisms linked to energy regulation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The molecular origin and triggers of GDF15 converge on reductive stress</head><p>Cells communicate with each other in part through cytokines, a family of small, secreted proteins. Some cytokines are produced by very specific cells to convey specific signals (e.g., between immune cells during an immune response), while other cytokines are expressed nonspecifically by several organs in response to stress <ref type="bibr" target="#b59">60</ref> , including the widely studied interleukin 6 (IL-6) <ref type="bibr" target="#b64">65</ref> . GDF15 is another small cytokine, often referred to as a metabokine (or mitokine) based upon its induction by metabolic stressors and mitochondrial disorders <ref type="bibr" target="#b65">66,</ref><ref type="bibr" target="#b66">67</ref> .</p><p>Several chemical and intracellular processes can trigger GDF15 <ref type="bibr" target="#b67">68,</ref><ref type="bibr" target="#b68">69</ref> , but a point of convergence for across stressors appears to be reductive stress <ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b69">70,</ref><ref type="bibr" target="#b70">71</ref> . Reductive stress sits at a biochemical hub and reflects the state of cellular electron flow <ref type="bibr" target="#b63">64</ref> . In breathing creatures like humans, energy flux converges in mitochondria, where oxidative phosphorylation (OxPhos) transforms food-derived electron flow into an electrochemical gradient used to synthesize ATP <ref type="bibr" target="#b6">7</ref> . But when oxidative capacity is limited or insufficient relative to the cellular energy demand, electrons face excess resistance and cannot as easily flow through the OxPhos system <ref type="bibr" target="#b71">72</ref> . This causes energy transformation deficiency and electron "backflow" <ref type="bibr" target="#b69">70,</ref><ref type="bibr" target="#b72">73</ref> . The biochemical consequence of this backflow is the accumulation of electrons on the electron acceptor NAD + , transforming it to its reduced form NADH.</p><p>The increase in NADH:NAD + ratio is a primary measure of reductive stress <ref type="bibr" target="#b69">70</ref> . It also drives cellular reprogramming across various contexts <ref type="bibr" target="#b63">64,</ref><ref type="bibr" target="#b73">74</ref> , and experiments manipulating the NADH:NAD+ ratio directly show that reductive stress alone is sufficient to trigger GDF15 secretion <ref type="bibr" target="#b69">70,</ref><ref type="bibr" target="#b70">71</ref> .</p><p>When the energy transformation capacity of a cell or tissue is exceeded by the cell's energy demand, reductive stress activates a highly conserved genetic program called the integrated stress response (ISR) through several potential mechanisms <ref type="bibr" target="#b74">75</ref> . Within the mitochondria, a high NADH:NAD+ ratio can limit TCA cycle function, causing amino acid starvation, thereby activation the ISR kinase GCN2 and downstream transcription factors including ATF4 and CHOP <ref type="bibr" target="#b69">70</ref> which in turn induces GDF15 expression <ref type="bibr" target="#b75">76</ref> . Additionally, mitochondrial dysfunction associated with elevated NADH levels can activate ISR via the OMA1-DELE1-HRI pathway <ref type="bibr" target="#b76">77</ref> . In this pathway, mitochondrial stress caused by disrupted ATP production activates the protease OMA1, which cleaves DELE1, releasing fragments that activate cytosolic HRI kinase and initiate the ISR through phosphorylation of eIF2α. Alternatively, reductive stress could indirectly induce ER stress through impaired ATPdependent protein folding and disturbed ER redox balance. This stress would trigger the ISR through activating the ER kinase PERK. The intracellular energy sensor AMP-activated protein kinase (AMPK) may also, at least in some certain cell types, trigger ISR activation and GDF15 production <ref type="bibr" target="#b77">78</ref> . Despite these proposed mechanisms, direct empirical evidence remains necessary to determine which ISR kinase most widely drives GDF15 production under physiological reductive stress conditions.</p><p>Once the ISR induces GDF15 gene expression, the resulting protein is synthesized and secreted as a GDF15 homodimer cytokine into the bloodstream (other variants may exist, see <ref type="bibr" target="#b68">69</ref> ). Carrying the signal of an energy gap from a cellular metaboceptor, GDF15 travels to the brain to close the "afferent" arm of mitoception.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mitochondrial defects are a direct trigger of GDF15</head><p>This mitochondria→ISR→GDF15 cascade has gained attention across fields of basic and clinical research. GDF15 is the leading circulating biomarker of mitochondrial OxPhos defects that cause rare mitochondrial diseases <ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref> . Compared to regular levels of GDF15, which are around 100-500 pg/ml in healthy middle-aged individuals with normal oxidative capacity, individuals with OxPhos defects can have chronically elevated GDF15 levels around &gt;1000-5000 pg/ml.</p><p>Another product of the ISR, fibroblast growth factor 21 (FGF21) is elevated in MitoD and signals onto the brain <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b78">79</ref> . FGF21 is upregulated by at least some arms of the ISR, but in comparison with GDF15, it is a more pleiotropic hormone regulated more strongly by fasting and feeding in ways that GDF15 is not <ref type="bibr" target="#b79">80</ref> . Thus, FGF21 and other molecules play important signaling roles in metaboception, but do not appear as specific mitoceptive signals in the same way as GDF15.</p><p>Experimentally, the mitochondriaàISRàGDF15 secretion signaling axis has been confirmed in cells where OxPhos defects are genetically or pharmacologically induced. Acutely interfering with electron flow in the OxPhos system upregulates GDF15 by several-fold, together with related transcription factors (e.g., ATF4/5) and coregulators (e.g., CHOP) <ref type="bibr" target="#b69">70,</ref><ref type="bibr" target="#b80">81,</ref><ref type="bibr" target="#b81">82</ref> . In one study where OxPhos was chronically inhibited with Oligomycin (inhibitor of the ATP synthase, 1nM), GDF15 expression was increased &gt;32-fold after 1-2 weeks <ref type="bibr" target="#b23">24</ref> . In vivo, selectively perturbing mitochondria by deletion of nuclear genes encoding OxPhos subunits or mtDNArelated proteins in mice triggers ISR induction and GDF15 production <ref type="bibr" target="#b82">83</ref> , and the same response is observed in humans with mtDNA mutations <ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b60">61</ref> . Thus, GDF15 is a robust marker of mitochondrial OxPhos defects that cause energy gaps (Figure <ref type="figure" target="#fig_0">2</ref>). GDF15 is secreted in various biofluids (blood, cerebrospinal fluid, saliva, urine, others). In the blood, GDF15 eventually reaches its cognate receptor in the area postrema of the brain to mobilize a dual energy conservation and mobilization response. Although the GDF15 protein is found and inducible in human saliva <ref type="bibr" target="#b49">50</ref> whether and how saliva GDF15 signals to the brainstem remains unknown.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GDF15 as a general marker of disease states</head><p>In addition to OxPhos defects, GDF15 expression and release into circulation is induced by several other energy-costly physiological states, although the underlying molecular pathways are, in many cases, not yet clear. For example, circulating blood GDF15 is elevated ~200-fold in pregnancy <ref type="bibr" target="#b83">84</ref> . It also increases exponentially ~100-150% on average per decade of life with aging <ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b84">85,</ref><ref type="bibr" target="#b85">86</ref> , making it a robust aging biomarker. There are also natural diurnal variations in mouse plasma GDF15 mRNA and muscle protein <ref type="bibr" target="#b86">87,</ref><ref type="bibr" target="#b87">88</ref> , and in human blood and saliva GDF15 protein <ref type="bibr" target="#b88">89,</ref><ref type="bibr" target="#b89">90</ref> .</p><p>In relation to disease, unbiased proteomic surveys searching for pan-disease markers have identified GDF15 as the most consistently elevated protein linked to any illness. Individuals with diagnoses of common chronic illnesses including cardiovascular disease <ref type="bibr" target="#b90">91</ref> , kidney disease 92 , cancer 93 , Alzheimer's disease <ref type="bibr" target="#b93">94,</ref><ref type="bibr" target="#b94">95</ref> autoimmune diseases 96 exhibit elevated circulating GDF15 concentration. Across dozens of medical diagnoses, GDF15 was the most consistently and significantly elevated circulating cytokine, over and above immune and non-immune cytokines like interleukins, growth factors, and others tissue-specific proteins <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40</ref> . Moreover, across two prospective studies, GDF15 predicted 10-20-year disease onset, including cognitive dysfunction and dementia <ref type="bibr" target="#b38">39</ref> , better than most other brain and non-brain proteins <ref type="bibr" target="#b38">39</ref> . Together, these findings demonstrate robust associations linking circulating GDF15 to costly metabolic conditions including human diseases and a spectrum of disease-related traits and symptoms. Why does GDF15 mark such a broad range of pathological states? Nothing in biology is "free" <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b96">97</ref> -every process costs energy and must be "funded" from a limited budget <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b72">73</ref> . As a result, energy is the most vital currency and consilience point in both health and disease. Taken from first principles, responding to sickness and the energetic cost of growth, maintenance, and repair (GMR) processes <ref type="bibr" target="#b22">23</ref> creates an energy sink. Like a tumor stealing energy away from surrounding tissues, disease-and stress-related energy sinks force trade-offs that redirect energy away from health-promoting processes, leaving other parts of the organism more vulnerable to the onset of further disease.</p><p>We propose that the reason why GDF15 is both elevated across dozens of diseases and disorders, and why it also is predictive of future incident disease <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40</ref> , is because GDF15 signals ongoing competition for energy within the constrained organismal energy budget <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b96">97</ref> . If one cell or organ experiences an energy gap, it saps energy from a competing system, curtailing its normal function(s) and ability to heal through GMR processes.</p><p>Interestingly, GDF15 is also elevated in conditions considered to exhibit and energy surplus, such as in diabetes and obesity <ref type="bibr" target="#b38">39</ref> , where circulating GDF15 levels scale with increase adiposity <ref type="bibr" target="#b68">69</ref> . The reason why metabolic surplus-or 'oversupply' relative to cellular energy demand-trigger GDF15 likely is because excess energetic substrates elevate NADH, thereby driving reductive stress <ref type="bibr" target="#b97">98,</ref><ref type="bibr" target="#b98">99</ref> . Thus, both excess electron influx or insufficient oxidation by mitochondria can drive reductive stress and GDF15 signaling. potentially indicative of the relative inability to transform energy relative efficiently <ref type="bibr" target="#b97">98</ref> .</p><p>Finally, this energetic perspective on health also positions stressors, such as chemotherapy 100 , or even responding to drugs that act by inhibiting mitochondrial OxPhos such as metformin 101 , as converging on the same energy gap, which culminates in GDF15 signaling.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Psychosocial stress elevates circulating GDF15</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cellular and experimental clinical studies</head><p>Both disease states and stress responses induce energetically costly processes and allostatic adaptations <ref type="bibr" target="#b22">23</ref> (see Figure <ref type="figure" target="#fig_0">2</ref>). As a result, hormones secreted during stress <ref type="bibr" target="#b21">22</ref> and mitochondrial OxPhos defects <ref type="bibr" target="#b23">24</ref> both increase overall energy expenditure (i.e., hypermetabolism). The common hypermetabolic effects of disease states and stress are likely driven by compensatory increases in cellular and physiological activities: gene expression, protein synthesis and secretion, physiological changes including increased heart rate and neural activity, and behavioral features including hormonal responses and increased muscle tone -all hallmarks of stress responses <ref type="bibr" target="#b24">25,</ref><ref type="bibr">102</ref> . It costs energy to "activate" anything. The stress response is, therefore, fundamentally an energetic response. And canonical "stress" systems 103 studied for nearly a century are deeply intertwined with metaboception.</p><p>If cells act as metaboceptors in which the ISR→GDF15 axis is non-specifically activated by an energy gap, then any threat or challenge that directly or indirectly increases energy demands (or is predicted to increase demands) should stimulate mitoception via the ISRàGDF15àGFRAL axis. In social animals, threats include perceived threats to one's physical and psychological identity (i.e., the self) or to one's social group. On the other hand, sociality and affiliation afford energy savings and are linked to longevity 104 .</p><p>Likely for this reason, social isolation or exclusion may represent energetically costly stressors that trigger the ISR→GDF15 axis, simultaneously activating energy-mobilizing "stress" axes such as the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS), which increase energy expenditure <ref type="bibr" target="#b22">23,</ref><ref type="bibr">105</ref> . Indeed, three independent studies show that socio-evaluative stress increases both blood and saliva GDF15 106,107 . After the onset of 5-10-min laboratory speech tasks, GDF15 increased on average by ~3-6% after 5-10 minutes in blood, and by ~28-43% within ~10-20 minutes in saliva <ref type="bibr" target="#b89">90</ref> . In both biofluids, GDF15 elevations occurred within minutes and were followed by rapid recovery (within 5-10 minutes) <ref type="bibr" target="#b89">90</ref> , a pattern consistent with pulsatile release of other metabolic and so called "stress" hormones. In mice, acute restraint stress similarly increased blood GDF15 108 . These experimental studies demonstrate that the rapid control of GDF15 secretion extends beyond cell-autonomous mechanisms and may also be driven by (systemic) reductive stress. Lactate, a metabolite whose concentration reflects tissue reductive stress (NADH/NAD + ), also transiently increases with mental stress alone both in humans <ref type="bibr" target="#b89">90</ref> and mice 109 . Thus, the energetically costly state of mental stress appears sufficient to rapidly trigger reductive stress and elevate circulating GDF15 in human biofluids.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epidemiological studies</head><p>The role of GDF15 in psychosocial stress is further supported by initial clinical and cohort studies linking psychopathology and adverse social circumstances to GDF15 levels. In studies of mental illness, relative to controls, individuals with psychiatric diagnoses of major depressive disorder, bipolar disorder and psychosis had 40-78% higher blood GDF15 levels <ref type="bibr">110- 114</ref> , with effect sizes of 0.35-5.2 (average 1.95, median 1.12, n=4 studies). This compares with other cytokines, including IL-6, IL-1b, TNFa, CRP, which have effect sizes ranging from -0.05-9.01 (average 1.41, median 0.41, n=45 studies) in depressive and bipolar disorders <ref type="bibr">[115]</ref><ref type="bibr">[116]</ref><ref type="bibr">[117]</ref> . Poverty, low household income, and low education levels associated with unfavorable social position were also linked to higher blood GDF15 <ref type="bibr">118,</ref><ref type="bibr">119</ref> .</p><p>In relation to social stressors, data from &gt;52,000 UK Biobank individuals in a proteomewide study of 2,920 plasma proteins, GDF15 was the top protein associated with perceived social isolation and loneliness 120 . Individuals struggling with community engagement or scoring high on neuroticism also exhibit elevated blood GDF15 levels 120 . These data support the existence of a link between psychosocial factors, energy, and metaboception. It is, however, important to consider that there are many other non-psychosocial factors in poverty that could contribute to increased energy demands and to mitoception. Importantly, participation in social activities involving energetically costly physical activity was negatively associated with GDF15 <ref type="bibr" target="#b38">39</ref> . This could potentially reflect the protective "energysaving" effects of a social support system (minimizing threat to the self), the benefit of physical activity in enhancing mitochondrial energy transformation capacity 121 , or other factors that prevent cellular energy gaps by either increasing capacity or reducing costs. Finally, individuals with comorbid mood disorders and physical illnesses (stroke and sex hormone imbalance) also exhibit higher blood GDF15 122-125 , possibly reflecting a compounded effect of biological and psychological challenges on circulating GDF15.</p><p>Altogether, these human data suggest that at least some cellular metaboceptors signal to the brain not only in response to physically injurious stimuli but also in response to perceived mental threats, acting to regulate the energetic state of the body. As reflected in post-stress blood lactate increases <ref type="bibr">106,</ref><ref type="bibr">109</ref> , mental stress appears to induce reductive stress (elevated NADH/NAD + ratio) within minutes via mechanisms that remain unknown. In line with such a threat-GDF15 connection, GDF15-deficiency in mice reduced the propensity to avoid open spaces (anxiety-related behaviors) 126 , while chronic GDF15 overexpression (ectopic skeletal muscle uncoupling protein 1 expression) led to more anxiety-related behaviors <ref type="bibr" target="#b87">88</ref> .</p><p>These findings suggest that states of mind are related to circulating GDF15 levels, both of which involve the brain, and raise the question of what it "feels" like to have elevated GDF15 concentrations in the blood-an issue explored in the next section.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Part 2 -EFFERENT ARM OF METABOCEPTION</head><p>Having discussed cellular, physiological, and psychosocial drivers of energy gaps and how they are translated into GDF15 within cells, in this section we discuss what happens when the brain senses the presence of GDF15. What kinds of responses and anticipatory states does the brain produce when it senses energy sinks?</p><p>We propose that the efferent arm of metaboception involves a dual response that simultaneously mobilizes energy resources to ensure plentiful supply to energetically deficient cells, while conserving energy at the whole-body level to by redirecting energy to areas of highest priority, balancing out the limited organismal energy budget. Finally, we discuss fatigue as the resulting integrated experience of mitoception, positioning fatigue as a transdiagnostic experience of energy gaps.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dual brain response to GDF15</head><p>Within cells, the energy-sensing ISR operates in a two-pronged manner. It transcriptionally suppresses energy consuming processes including protein synthesis 127 to address energetic demand challenges, while simultaneously activating processes that recruit energetic resources 128 and address energetic supply challenges. Similarly, cellular and organismal energy sensing systems aim to promote survival via a dual response that simultaneously conserves and mobilizes energy <ref type="bibr" target="#b13">14</ref> .</p><p>A useful analogy to metaboception and mitoception is nociception, where a stimulus is transformed into an experience. Nociception processes a painful stimulus and elicits the appropriate dual response to ensure the organism's safety (Figure <ref type="figure" target="#fig_1">3</ref>, top). In this context, we can conceive of a cellular energy gap as kind of "energetic pain". Below we describe how the brain responds to mitoceptive stimuli in two main ways: 1) by mobilizing energy from existing reserves, and 2) by conserving energy normally directed to energetically costly, but not acutely essential, processes (Figure <ref type="figure" target="#fig_1">3</ref>, bottom). A skin wound is transduced into pain by nociceptors, transmitted to the brain via small caliber, unmyelinated nerve fibers where they activate specialized brain areas involved in nociception. These brain areas project onto complex brain circuitry that unleash a dual, pro-survival conservation or preservation strategy, and an arousal response that mobilizes energy resources to face the potential injury or threat. Mitoception operates following a parallel system. The cellular energy gap is transduced into energetic pain by the reductive stress/ISR system, transmitted to the brain via the blood-secreted protein GDF15 that activates GFRAL-positive neurons in the area postrema, involved in sensing circulating toxins and other noxious substances. The area postrema projects onto complex brain circuitry to unleash a dual response involving multi-system energy conservation (i.e., fatigue, sickness behavior (Sx), social withdrawal) and energy mobilization (i.e., glucocorticoids, catecholamines cooperating to increase glucose and fatty acid concentrations in the blood).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Energy mobilization</head><p>Energy mobilization involves recruiting and diverting existing energetic resources from one part of the organism towards the systemic circulation, or towards the cells/tissue in need. One example is during exercise where blood is shunted away from digestive organs, towards active muscles. Endocrine examples of energy mobilization include the release of glucose into the blood by the liver in response to stress mediators such as glucocorticoids, catecholamines and cytokines 129 , and of fatty acids from adipose tissue 130 . These "stress response" axes are in fact energy mobilization axes, co-opted during evolution by the brain/mind system to mobilize energetic resources to feed stress responses 131 . GDF15, together with GFRAL, has also been shown to be involved in such responses.</p><p>Studies in mice have demonstrated that activation of the GDF15àGFRAL axis in the brain activates the HPA and SNS axes and contributes to anxiety. This induces corticosterone and adrenaline release <ref type="bibr" target="#b52">53,</ref><ref type="bibr">100,</ref><ref type="bibr">132</ref> which can trigger the breakdown of energy stores through lipolysis and gluconeogenesis to maintain blood sugar <ref type="bibr" target="#b52">53</ref> , thereby providing energetic resource delivery to meet the acute energy requirements of the energetically aching cells/tissue of origin 128 . Although GDF15 itself has not yet been directly shown to increase glycogen breakdown or gluconeogenesis, GFRAL+ signaling stimulates lipid oxidation <ref type="bibr" target="#b52">53</ref> . Effects of GDF15 on lipolysis in adipose tissue 133 and on glucose regulation and insulin sensitivity <ref type="bibr" target="#b68">69,</ref><ref type="bibr">134</ref> also contribute to the notion that GDF15 plays a role in redistributing energy across the organism.</p><p>In humans, individuals who are energetically challenged, such as patients with mitochondrial disease and primary OxPhos defects, exhibit an endocrine signature of SNS hyperactivation and energy mobilization <ref type="bibr" target="#b44">45,</ref><ref type="bibr">[135]</ref><ref type="bibr">[136]</ref><ref type="bibr">[137]</ref> . As mentioned above, excessive SNS activation occurs alongside elevated circulating GDF15, although it remains unclear whether basal levels of circulating GDF15 contributes to SNS hyperactivation in humans (or vice versa, or unrelated).</p><p>Robust evidence also shows that circulating GDF15 signaling contributes to anxiety-like behavior in mice 108 , and that the anxiogenic effects of injected adrenaline depend on the GDF15àGFRAL body-to-brain signaling axis 108 . GDF15 was also the most strongly upregulated protein associated with anxiety in the UK Biobank <ref type="bibr" target="#b38">39</ref> . Furthermore, both SNS activity and GDF15 are elevated as we age <ref type="bibr" target="#b84">85,</ref><ref type="bibr" target="#b85">86</ref> , possibly reflecting the energetic mobilization required to fuel the costly stress responses (repair of accumulated damage and compensation) during aging 138 .</p><p>The recently uncovered role of GDF15 in triggering the classic autonomic nervous system and neuroendocrine stress responses provides a new perspective on past studies of acute and chronic stress. In past studies of human participants experiencing psychosocial stress, physiological stress and cortisol, SNS-derived hormones including catecholamines in blood or urine, and metabolic/cardiovascular markers such as elevated blood glucose and lipids were previously understood to be part of the most rapid and proximal stress responses. But given that mental stress induces GDF15 that interact with other neuroendocrine factors within minutes <ref type="bibr" target="#b89">90</ref> , it is possible that GDF15 could act simultaneously and interactively with classical "stress response" axes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Energy conservation</head><p>Energy conservation involves sparing portions of the organism's limited energy budget by suppressing behaviors and functions not essential to survival <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b96">97</ref> . Acutely de-prioritized systems may include cellular growth, maintenance and repair (GMR) processes, as well as digestion, higher order cognitive processes, maintaining body temperature, and sustaining the intensity or amount of physical activity 139 . The NADH:NAD+ ratio reflects the resistance to electron flow (energy resistance, éR) <ref type="bibr" target="#b71">72</ref> , which we refer to here as the energy gap. In flies, this directly shapes behaviors, driving the pressure to sleep 140 . Similarly in humans and other animals, GDF15 signaling of an energy gap could underlie behavioral changes that aim to conserve energy, including but not limited to fatigue.</p><p>Perhaps one (counterintuitive) way to rapidly save energy is to fast. While there is a net long-term energetic resource gain to forage, find and eat food, in the short-term anorexia conserves energy because digestion-like everything else in biology-costs energy: 5-10% of total daily energy expenditure is used to digest 141 . Not eating may spare this portion of the energy budget. At physiological levels, GDF15 is a known anorectic and nausea-inducing signal, reducing the motivation to eat <ref type="bibr" target="#b40">41,</ref><ref type="bibr">142,</ref><ref type="bibr">143</ref> . As proposed previously <ref type="bibr" target="#b33">34</ref> , nausea and vomiting might also prevent the ingestion of toxins. In line with that idea, morning sickness or hyperemesis gravidarum during the early stages of pregnancy caused by elevated GDF15 <ref type="bibr" target="#b40">41</ref> have been proposed as a mechanism to guard the organism against potentially costly and harmful exposures. However, more work investigating the potential immediate energetic consequences of GDF15-induced anorexia, nausea and emesis is required to fully understand its role in mitoception in general, and whether this contributes to energy conservation.</p><p>The GDF15àGFRAL axis also conserves energy. In mice, GDF15 signaling decreases body temperature and achieves an energy-saving torpor-like state <ref type="bibr" target="#b52">53</ref> . In humans, among individuals with primary mitochondrial OxPhos defects, as in many chronic illnesses <ref type="bibr">144,</ref><ref type="bibr">145</ref> , the most common symptom is fatigue: the subjective experience of lacking energy and the capacity for doing things, likely reflecting the need to conserve energy to close the energy gap. Among patients with mitochondrial diseases, physical and mental fatigue are associated (r=0.27-0.53) with circulating GDF15 <ref type="bibr" target="#b60">61</ref> . Together with preclinical work linking GDF15 signaling to torpor <ref type="bibr" target="#b52">53</ref> , these finding suggests that GDF15 may promote energy conservation by inducing fatigue (Box 2).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Does mitoception induce fatigue to conserve energy?</head><p>The experience of fatigue alters behavior to promote survival by reducing energy expenditure <ref type="bibr" target="#b4">5</ref> . People experience fatigue during or after energetic challenges including vigorous exercise and sickness. Decreased motivation to engage in physical, mental and social activities, and feeling weak and inclined to rest together with other negative valence emotions decrease unnecessary energy expenditure. This phenomenon, known as "sickness behavior," is understood to (re)allocate energetic resources to prioritize urgent recovery and healing processes <ref type="bibr" target="#b4">5</ref> , as in the context of aging and frailty <ref type="bibr" target="#b25">26</ref> and recovery from injury and infection 146 .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Psychological stressors contribute to fatigue</head><p>The experience of fatigue is also associated with psychiatric disorders such as depression and anxiety, as well as negative psychosocial factors including psychological stress, and early life adversity. Table <ref type="table" target="#tab_0">1</ref> summarizes associations between psychiatric disorders and psychosocial exposures with the experience of fatigue. The body of evidence linking psychosocial stressors to fatigue appears magnified in the disease-related fatigue literature. Fatigue is greater in those reporting negative psychosocial factors, whereas those reporting more positive psychosocial factors experience less fatigue 147-154 . This apparent compounding effect of psychosocial and diseases-related stressors on fatigue could relate to the fact that both psychosocial stress (see above) and diseases independently increase circulating GDF15.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Emotional well-being is related to lower fatigue</head><p>In contrast, negative associations have been found between fatigue and positive psychosocial factors such as social support and optimism (see Table <ref type="table" target="#tab_0">1</ref>). This suggests that positive psychosocial factors could allow an individual to either mitigate or minimize the impact of energetic challenges and deficits. The exact mechanisms for their potential buffering effects need to be explored further. This includes whether they are buffering the direct effects of stress or if they have direct effects themselves. Positive resources such as support and emotional wellbeing can impact physiology both through direct effects as well as moderators of stress effects <ref type="bibr">105,</ref><ref type="bibr">155</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GDF15 as a nexus for psychosocial stress, fatigue, and metabolic disease?</head><p>We propose the hypothesis that psychosocial and disease factors represent energetic challenges that act via GDF15 to produce fatigue. We experience fatigue when energy expenditure exceeds our system's actual or predicted ability to transform energy. As introduced by Dantzer 5 , our immune system can subjugate the brain into rest/recovery mode 5 , preserving energy resources to fuel the most vital processes <ref type="bibr" target="#b25">26</ref> , including immune processes 156 . Beyond immune activation and injury, several psychosocial factors have been related to the experience of fatigue (Table <ref type="table" target="#tab_0">1</ref>). Could psychosocial and other lived experiences affect our perception of energy and fatigue via GDF15? If GDF15 induces fatigue, the mental stress→GDF15→fatigue axis could explain why psychosocial stressors, traumatic exposures, and mental illness promote fatigue (along with cytokine release). This axis would be adaptive via its ability to promote energy conservation, thus allowing redirection of energetic resources to face the primary stressor <ref type="bibr" target="#b22">23</ref> . This notion is indirectly supported by evidence showing that GDF15 is elevated in several diseases and in aging <ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b84">85,</ref><ref type="bibr" target="#b85">86</ref> , states where individuals also report fatigue 144 . Work in elderly populations also demonstrate a positive association between GDF15 levels and frailty, including measures of exhaustion and weakness <ref type="bibr">157,</ref><ref type="bibr">158</ref> . Psychosocial factors including rest, social habits and conviviality that modify GDF15 levels 159 also contribute to fatigue and frailty <ref type="bibr">160,</ref><ref type="bibr">161</ref> . Preliminary findings from the UK Biobank show that feelings of low energy, aversion to physical activities such as taking the stairs and walking for pleasure, an inability to participate physically and mentally in social activities, along with a number of negative psychological states are linked to elevated GDF15 (Table <ref type="table">2</ref>) <ref type="bibr" target="#b38">39</ref> . The reasons for the associations between poverty/household income with GDF15 could be many, mediated by physical factors such as the environment, underlying biological or biochemical conditions, or medication. Nonetheless, facing such challenges is predicted from the energetic cost of stress responses 23 be energetically demanding. One interpretation is that individuals with elevated GDF15-indicative of chronic energetic deficiency-develop an aversion to mental, physical, and social factors that could further drain their energy reserves.</p><p>Further work, however, is needed to investigate the direct and indirect effects of stressors on fatigue and other (negative or positive) subjective experiences, and their potential mediation by circulating GDF15. Box 2 highlights the type of studies needed, spanning different levels of spatial and temporal resolutions, to decipher how GDF15 interact with other factors to shape states of mind and human behaviors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GDF15: context matters</head><p>Complex human experiences are not defined by single factors. How an individual experiences GDF15 as a signal for energetic deficiency and fatigue may vary depending on the context under which it is experienced. For example, exercise acutely increases GDF15 (like other cytokines) within minutes to hours, but lowers baseline circulating GDF15 in those who exercise regularly <ref type="bibr" target="#b43">44</ref> . It is also possible that acute exercise induces elevated GDF15 through intermediate processes, such as ER stress <ref type="bibr">162,</ref><ref type="bibr">163</ref> . Exercise induced mitochondrial biogenesis 164 and a related increase in the individual's energy transformation capacity 121 driven by elevated mitochondrial density could make daily challenges relatively less energetically "stressful," buffering against reductive stress, contributing to lower baseline GDF15 levels in trained individuals <ref type="bibr" target="#b43">44</ref> . However, when GDF15 remains chronically elevated, the sustained suppression of appetite and exercise avoidance may become maladaptive. In cancer cachexia, where GDF15 is elevated, blocking its signaling with an antibody may help prevent muscle loss <ref type="bibr">165</ref> . In animals, removing the area postrema entirely also helps prevent peripheral effects 166 . With aging, the loss of muscle mass and frailty in sarcopenia could be in part driven by GDF15-based mitoception, as an attempt of the brain to conserve energy 138 .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion and Outlook</head><p>We propose that the mitoception arm of metaboception is conveyed in part by the Energy gap→ISR→GDF15→Brain→Fatigue cascade (Figure <ref type="figure" target="#fig_2">4</ref>). Mitoception thus produces an integrated psychobiological state, which (although uncomfortable) likely promotes energy balance the face of energy-consuming events in the short term <ref type="bibr" target="#b25">26</ref> . In the long term, this energyconservation axis is predicted to promote health and survival 138 . Since mind and body converge and share the same energetic circuitry <ref type="bibr" target="#b21">22</ref> , metaboception in general and mitoception in particular would naturally shape subjective experiences, physiology, behaviors and health outcomes.</p><p>An energetic perspective on health and disease operationalized by the mitoceptive bodyto-brain GDF15 signaling axis leads to several Outstanding Questions ranging from mechanistic details of mitoception to neural pathways underlying the interaction between positive experiences of vigor, vitality, purpose in life, and well-being, and how they intersect with GDF15 levels and fatigue.</p><p>In summary, our model of mitoception suggests that GDF15 conveys the gap between energy demand and transformation capacity in mitochondria to the brain. The purpose of this signaling axis is to preserve optimal functioning, in part by shaping a felt sense of energy deficiency. An organism's energy budget is finite and must be efficiently managed <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b96">97</ref> . By bidirectionally monitoring and regulating energy metabolism, mitoception in concert with other cellular and systemic metaboceptive pathways thus redirect the organism's limited energetic resources towards processes that promote allostasis and well-being.</p><p>The convergence of psychobiological processes onto energy and metaboception opens new exciting avenues to build a holistic understanding of the processes underlying human health across the lifespan. relative to mitochondrial energy transformation capacity. This activates the integrated stress response (ISR) via reductive stress (elevated NADH/NAD + ratio), triggers extracellular GDF15 release, which travels to the brain through the bloodstream. GDF15 is rapidly inducible by acute physical, biochemical, and mental stressors, and GDF15 increases exponentially with age (upper left box, data from 167 ), outlining factors that must be considered when designing and interpreting human studies. Other metabolites (e.g., lactate, a signal of reductive stress) and proteins (e.g., FGF21) can act as mitoception signals under certain conditions. Efferent arm: In response to GDF15, the brain deploys a dual i) energy conservation and ii) energy mobilization strategy, shutting down acutely-dispensable energy expensive physiological processes, and recruiting energy substrates form energy stores. Through mitoception, the brain monitors and regulates the balance between cellular energy demand and mitochondrial transformation capacity. Evidence and action of signals may act at different scales (lower left box).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Box 1. Intracellular and systemic inter-organ energy sensing mechanisms.</head><p>INTRACELLULAR ENERGY SENSING. Cells sense energy levels in a cell-autonomous manner via intracellular sensors such as AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), NAD + -dependent sirtuins, and the integrated stress response (ISR). These molecular sensors capture intracellular levels of energy intermediates such as ATP and its lower energy versions ADP/AMP, or the redox ratio NAD + :NADH. To operate harmoniously as an organism, cells must also sense the energetic state of their surrounding cells. Thus, most cells express cell surface receptors for extracellular ATP and other metabolic intermediates such as lactate <ref type="bibr" target="#b45">46,</ref><ref type="bibr">168</ref> , which allows cells to sense the status of the shared "social" space between the cell collective <ref type="bibr" target="#b48">49</ref> . Such signals from the cytoplasm or the cell surface are then transmitted to the cell nucleus where they mobilize the appropriate gene expression programs evolved to enhance cellular fitness. These programs can induce cell-autonomous recalibrations, including mitochondrial biogenesis (the production of additional mitochondria) and upregulate other metabolic pathways, or involve the secretion of cytokines such as GDF15 and interleukins, to alert other cells of their energy deficiency (Figure , <ref type="figure">left</ref>).</p><p>INTER-ORGAN COMMUNICATION. The brain also senses systemic energy levels. In dedicated brain regions, specialized neurons sense glucose and fatty acids from the surrounding bloodstream, subsequently activating downstream circuits that orchestrate hormone secretion, metabolic activities, and food seeking behaviors <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr">[169]</ref><ref type="bibr">[170]</ref><ref type="bibr">[171]</ref> . Sensors scattered in blood vessels near the heart and in the brain detect the vital gases: oxygen (O2, the primary substrate for mitochondrial energy transformation) and CO2 (the primary by-product of respiration) 172 . Both low O2 and high CO2 are key signals of low energy status. The emotional salience and physical discomfort (i.e., panic from asphyxiation) of oxygen deficiency and excess CO2 reflect the vital importance of these signals for our biology -running out of fuel for mitochondria would be the end of both the body and mind.</p><p>The brain also senses signals from the stomach (ghrelin) and the small intestine (GLP-1, CCK) to regulate food seeking/eating relative to other organismal priorities over short periods of time (hours, days) 1 , whereas signals from adipocytes (leptin) 173 allows organism to regulate energy intake and expenditure over long time periods (weeks, months). Immune cell cytokine signals are also sensed by the brain to facilitate reallocation of energetic resources from behavior and active energy expenditure towards fighting infection (sickness behavior) <ref type="bibr" target="#b4">5</ref> , and skeletal myocytes signal via myokines (e.g. IL6) to inform the brain of activity intensity relative to aerobic fitness <ref type="bibr" target="#b15">16</ref> . This set of endocrine inter-organ communication system forms an interoceptive network, signaling the abundance or scarcity of energy resources. In response to signals of energy deficiency, the brain also has multiple mechanisms to translate these signals into conscious experiences (e.g., hunger, fatigue) and physiological responses that promote survival in the face of energy scarcity. (Figure, right). Converging intracellular and brain-based systemic metaboceptive mechanisms have evolved to sense and respond to the scarcity of energetic resources, both in the short and long-term.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Box 2. Empirical approaches and considerations to elucidating GDF15 psychobiology</head><p>Defining the role of GDF15 in linking psychosocial factors, fatigue, and other energetic challenges will require the following types of studies:</p><p>1. Large-scale epidemiology. Large datasets with multidimensional biological and psychosocial variables can be used to test whether GDF15 statistically mediates the relationship between exposures (e.g. exercise, sleep deprivation, injury, immune challenges) on outcomes variables of interest, such as fatigue and anxiety. Strengths of this approach include the ability to control for numerous confounders (e.g., age, sex, SES status); limitations include the cross-sectional nature of data and the occasional imperfect timing of biological and psychosocial measures.</p><p>2. Longitudinal observational. Studies with repeated measures of GDF15 and/or psychosocial variables can reveal meaningful temporal associations pointing to the impact of energy gaps on psychosocial, psychiatric and clinical outcomes, and vice versa.</p><p>3. Clinical studies with greater temporal resolution. Studies measuring GDF15 at a scale of minutes to hours are necessary to temporally and accurately relate changes in GDF15 to changes in mood, physiology, symptoms, and/or complex behaviors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Controlled clinical interventions.</head><p>To determine the specific and direct effects of GDF15 on mood, physiology, symptoms, and/or complex behaviors, controlled studies involving psychological, behavioral or pharmaceutical interventions are required.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Mechanistic studies of GDF15 signaling.</head><p>To establish if GDF15 is sufficient and necessary to mediate the effects of cellular energy gaps on organismal functions, mechanistic studies involving cell-based in vitro, in vivo in animal models may be required. Human studies using neutralizing antibodies to block body-to-brain GDF15 signaling 165 are valuable.</p><p>Some technical and conceptual considerations for investigating GDF15 psychobiology include:</p><p>1. Age. GDF15 displays an unusually strong (rs=0.5-0.8, depending on the age range examined) exponential relationship with age <ref type="bibr" target="#b35">36,</ref><ref type="bibr">167</ref> . Computing the residual of GDF15 exponentially regressed onto age (log GDF15 linearly regressed to age) or using partial correlation between log GDF15 and the variable of interest, adjusting for age, can account for this effect.</p><p>2. GDF15 variants. In the 1000 Genome Project 23% of the population carried the H202D GDF15 variant 174 (estimated to be ~15-30% of global populations). This variant is under-detected by the commonly used R&amp;D ELISA kit when compared to the Roche Elecsys assay 175 . When measuring GDF15, the limitations of the method and possibility of under detection should be considered.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.</head><p>Pregnancy. Given the ~200-fold increase in blood GDF15 with pregnancy 84 , pregnancy is an important confounder that must be objectively assessed.</p><p>4. Diurnal GDF15 patterns. Given evidence of diurnal variation in some animals <ref type="bibr" target="#b86">87,</ref><ref type="bibr" target="#b87">88</ref> and humans studies <ref type="bibr" target="#b88">89,</ref><ref type="bibr">106</ref> , GDF15 should be systematically measured at specific times of day.</p><p>5. GDF15 stability. Some analytes degrade progressively with storage time. Evidence of GDF15 stability with cryostorage is limited, but it is fair to assume at least moderate protein stability since it is reliably quantified even after ~5-20 years of storage via proteomics 39 , ELISA <ref type="bibr" target="#b60">61</ref> . Storage time could possibly be a covariate in longitudinal studies.</p><p>6. Safety. In mechanistic human studies, manipulating GDF15 levels could have unanticipated sideeffects. However, GDF15-deficient individuals appear phenotypically normal when under basal conditions 176 , and neutralizing endogenous GDF15 appears well-tolerated 165 . Treatment with recombinant GDF15 did not cause well-known unanticipated major problems, but the short half-life of GDF15 (3 hours in monkeys) 177 and the poor tolerability due to gastrointestinal disorders (nausea and vomiting) should be considered <ref type="bibr">143,</ref><ref type="bibr">178</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OUTSTANDING QUESTIONS</head><p>-Is GFRAL expression exclusively confined to area postrema brain neurons, or are other GDF15 receptors expressed in other cell types in peripheral (non-brain) organs?</p><p>-Does GDF15 play a role in wound healing, sleep, or other restorative processes?</p><p>-How do biological/physiological variables including hormones, metabolic, immune, and other blood biomarkers contribute to regulate baseline and stress-reactive GDF15?</p><p>-Does circulating GDF15 exhibit diurnal regulation? If so, what is the magnitude and pattern relative to other neuroendocrine and metabolic factors?</p><p>-Do chronic psychosocial stressors such as loneliness, adversity, workplace stress, discrimination and others elevate circulating GDF15?</p><p>-Do interventions that increase well-being, including mindfulness, relaxation, psychedelic-assisted therapy, and others decrease circulating GDF15?</p><p>-How robust are blood and saliva GDF15 as markers of psychosocial stress compared to cortisol and other bona fide stress hormones? What are the dynamics and effect sizes of GDF15 changes after psychological stress in different populations (ages, sex, health status, etc.)?</p><p>-What transdiagnostic features of psychopathology (e.g., anhedonia) relate to circulating GDF15 in depression, anxiety, PTSD, schizophrenia, and other mental illnesses?</p><p>-Can vicarious experiences of stress and pain, or well-being, influence GDF15?</p><p>-Is there a reliable brain signature of systemic energy gaps reflected in elevated circulating GDF15? Is this signature responsive to interventions and the healing process that resolve energy gaps?</p><p>-Does GDF15 constrain mood and the emotional state space of possible human experiences? Is GDF15 associated with valence emotions? Table 2. Preliminary associations between psychosocial, behavioral and fatigue-related traits, and mental illnesses, and GDF15 in the UK Biobank. TRAITS ASSOCIATED WITH GDF15 GDF15 effect direction Effect size (β) [95%CI] SE P-value Feelings of fatigue Waking unrefreshed severity over the past week ↑ 0.26 [0.19-0.33] 0.035 4.00*10 -14 Recent feelings of tiredness or low energy ↑ 0.24 [0.16-0.30] 0.036 6.86*10 -11 Feeling tired or having little energy over the last two weeks ↑ 0.32 [0.25-0.39] 0.038 8.81*10 -20 Physical impairments/impairments to daily life Mobility problems today ↑ 0.45 [0.37-0.52] 0.030 9.74*10 -30 Self-care problems today ↑ 0.47 [0.37-0.58] 0.053 7.21*10 -19 Problems doing usual activities ↑ 0.39 [0.28-0.43] 0.038 5.74*10 -21 Social/Physical Activities Sports and social activities attended in person at least once a week_ Sports club or gym or fitness class ↓ -0.27 [-0.95--0.18] 0.043 5.89*10 -10 Types of physical activity in the last 4 weeks_ Walking for pleasure (not as a means of transport) ↓ -0.35 [-0.38--0.31] 0.020 1.83*10 -69 Liking taking the stairs ↓ -0.24 [-0.41--0.29] 0.031 1.61*10 -28 Sports and social activities attended in person at least once a week_ Sports club or gym or fitness class ↓ -0.27 [-0.95--0.18] 0.043 5.89*10 -10 Negative psychosocial states Neuroticism score ↑ 0.12 [0.08-0.18 0.018 3.53*10 -11 PREVALENT DISEASES GDF15 effect direction OR [95%CI] P value Smoking dependency ↑ 2.60 [2.15-3.15] 5.01*10 -23 Alcohol dependence ↑ 2.24 [1.87-2.69) 1.50*10 -18 Substance abuse, excluding more controls ↑ 2.18 [1.94-2.45) 8.14*10 -39 Any mental disorder ↑ 2.16 [1.99-2.34] 3.08*10 -80 Mood disorders, excluding more controls ↑ 2.15 [1.94-2.37] 8.78*10 -51 Depression or dysthymia ↑ 2.02 [1.81-2.26] 9.88*10 -36 Alcohol use disorder, ICD-based ↑ 2.02 [1.74-2.35] 1.50*10 -20 Depression ↑ 1.96 [1.77-2.17] 6.20*10 -37 Schizophrenia or delusion, excluding more controls ↑ 1.94 [1.61-2.33] 3.20*10 -12 Mental and behavioural disorders due to alcohol, excluding acute intoxication ↑ 1.90 [1.66-2.17] 3.68*10 -21 Anxiety disorders, excluding more controls ↑ 1.65 [1.40-1.93] 9.06*10 -10</p><p>Data from the UK Biobank atlas of plasma proteins (Deng et al. Cell 2025, <ref type="url" target="https://proteome-phenome-atlas.com/">https://proteome-phenome-atlas.com/</ref>), which examined 2,920 plasma proteins in relation to disease prevalence and incidence (406 prevalent and 660 incident) as well as 986 health-related traits in 53,026 individuals. Associations between plasma proteins and health-related traits were assessed using linear regression for continuous traits (as outcome) and binary traits (as exposures), while proportional odds logistic regression was applied for ordered categorical traits. All regressions were performed with the adjustment of participants' baseline information of age, sex, ethnicity, Townsend deprivation index, Body-Mass Index (BMI), smoking status, fasting time, season of blood collection (summer/autumn: June to November versus winter/spring: December to May) and blood age (date of blood collection to date of protein examination).</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. Triggers of GDF15 secretion converge on energy deficiency, reductive stress, and ISR activation. Stressors trigger the activation of molecular, organellar and cellular behaviors that cost energy. In many well documented cases, physical, chemical, and mental stressors produce reductive stress reflected in the increase in the NADH/NAD+ ratio and lactate production. Reductive stress is a potent trigger of the integrated stress response (ISR), a gene program that inhibits certain costly cellular operations, and signals to other cells the presence of energetic stress via extracellular GDF15 secretion.GDF15 is secreted in various biofluids (blood, cerebrospinal fluid, saliva, urine, others). In the blood, GDF15 eventually reaches its cognate receptor in the area postrema of the brain to mobilize a dual energy conservation and mobilization response. Although the GDF15 protein is found and inducible in human saliva<ref type="bibr" target="#b49">50</ref> whether and how saliva GDF15 signals to the brainstem remains unknown.</figDesc><graphic coords="9,72.99,72.99,468.00,171.10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Mitoception via GDF15 mirrors nociception.A skin wound is transduced into pain by nociceptors, transmitted to the brain via small caliber, unmyelinated nerve fibers where they activate specialized brain areas involved in nociception. These brain areas project onto complex brain circuitry that unleash a dual, pro-survival conservation or preservation strategy, and an arousal response that mobilizes energy resources to face the potential injury or threat. Mitoception operates following a parallel system. The cellular energy gap is transduced into energetic pain by the reductive stress/ISR system, transmitted to the brain via the blood-secreted protein GDF15 that activates GFRAL-positive neurons in the area postrema, involved in sensing circulating toxins and other noxious substances. The area postrema projects onto complex brain circuitry to unleash a dual response involving multi-system energy conservation (i.e., fatigue, sickness behavior (Sx), social withdrawal) and energy mobilization (i.e., glucocorticoids, catecholamines cooperating to increase glucose and fatty acid concentrations in the blood).</figDesc><graphic coords="13,72.99,87.54,468.00,265.20" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 4 .</head><label>4</label><figDesc>Figure 4. The mitoceptive subset of metaboception. Afferent arm: cellular metaboceptors distributed across human tissues (bottom) sense the energy gap driven by excess energy demand or expenditure</figDesc><graphic coords="18,72.99,72.99,468.00,600.10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="20,72.99,100.19,468.00,209.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Empirical rationale for examining GDF15 levels in relation to positive and negative psychosocial factors linked to increased fatigue in human studies Psychosocial construct Evidence related to fatigue NEGATIVE</head><label>1</label><figDesc>Anxiety↑ frailty in elderly (Fatigue, Resistance, Ambulation, Illness, and Loss of Weight scales) 160 ↑ mental fatigue in healthcare workers during COVID19 182 Psychological distress ↑ frailty in elderly w increased PSS (Fatigue, Resistance, Ambulation, Illness, and Loss of Weight scales) 160 ↑ frailty in elderly 183 PTSD ↑ mental fatigue in healthcare workers during COVID19 182 ↑ fatigue in healthcare workers 184</figDesc><table><row><cell></cell><cell>Chronic stress</cell><cell>↑ fatigue with caregiver stress 179</cell></row><row><cell></cell><cell></cell><cell>↑ fatigue with job-related stress 180</cell></row><row><cell></cell><cell>Depression</cell><cell>↑ frailty in elderly (Fatigue, Resistance, Ambulation, Illness, and Loss of Weight</cell></row><row><cell></cell><cell></cell><cell>scales) 160</cell></row><row><cell></cell><cell></cell><cell>↑ fatigue 181</cell></row><row><cell></cell><cell>Burnout &amp; workplace stress</cell><cell>↑ fatigue 185,186</cell></row><row><cell></cell><cell>Loneliness</cell><cell>↑ fatigue 187,188</cell></row><row><cell></cell><cell></cell><cell>↑ fatigue, ↓ energy (n.s.) 189</cell></row><row><cell></cell><cell>Early life adversity (ELA)</cell><cell>↑ fatigue 181</cell></row><row><cell></cell><cell>Social support</cell><cell>↓ fatigue during COVID19 lockdown (mediated by stress, worry, COVID19</cell></row><row><cell>POSITIVE</cell><cell>Mindfullness</cell><cell>worries) 190 ↓ fatigue 181 ↓ fatigue in perimenopausal women 191</cell></row><row><cell></cell><cell>Optimism</cell><cell>↓ fatigue 192</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgements</head><p>We are grateful to the members of the <rs type="institution">Mitochondrial Psychobiology Group</rs> for stimulating discussions and input.</p></div>
			</div>
			<div type="funding">
<div><head>Funding</head><p>Work of the authors is supported by <rs type="grantNumber">R01MH119336</rs>, <rs type="grantNumber">R01MH122706</rs>, <rs type="grantNumber">R01AG066828</rs>, <rs type="grantNumber">R21MH123927</rs>, <rs type="grantNumber">R01AG076821</rs> and <rs type="funder">Baszucki Brain Research Fund</rs> to M.P., <rs type="grantNumber">RF1AG076821</rs> to M.P. and T.W., and the <rs type="funder">Wharton Fund</rs> to M.P. and C.T.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_sN6Y68s">
					<idno type="grant-number">R01MH119336</idno>
				</org>
				<org type="funding" xml:id="_4WCadsx">
					<idno type="grant-number">R01MH122706</idno>
				</org>
				<org type="funding" xml:id="_xuaRQSZ">
					<idno type="grant-number">R01AG066828</idno>
				</org>
				<org type="funding" xml:id="_UjVaDay">
					<idno type="grant-number">R21MH123927</idno>
				</org>
				<org type="funding" xml:id="_6ATzYVJ">
					<idno type="grant-number">R01AG076821</idno>
				</org>
				<org type="funding" xml:id="_yj2dCb7">
					<idno type="grant-number">RF1AG076821</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p>The authors have no competing interests to declare. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The physiological control of eating: signals, neurons, and networks</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Kanoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sanchez-Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Langhans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiological reviews</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="689" to="813" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Integrative neurocircuits that control metabolism and food intake</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Brüning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fenselau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="page">7398</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Immunoception: Defining brain-regulated immunity</title>
		<author>
			<persName><forename type="first">T</forename><surname>Koren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rolls</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2022.10.016</idno>
		<ptr target="https://doi.org:10.1016/j.neuron.2022.10.016" />
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="3425" to="3428" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Central regulation of stressevoked peripheral immune responses</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Poller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Russo</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41583-023-00729-2</idno>
		<ptr target="https://doi.org:10.1038/s41583-023-00729-2" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Neurosci</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">From inflammation to sickness and depression: when the immune system subjugates the brain</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dantzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>O'connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Freund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Kelley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews neuroscience</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="46" to="56" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Functions of interoception: From energy regulation to experience of the self</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Quigley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kanoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Grill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsakiris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends in neurosciences</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="29" to="38" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Energy transduction and the mind-mitochondria connection</title>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Biochemist</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="14" to="18" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Grill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell metabolism</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="296" to="309" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Neuronal regulation of energy homeostasis: beyond the hypothalamus and feeding</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Waterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Horvath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell metabolism</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="962" to="970" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Gut-Brain Cross-Talk in Metabolic Control</title>
		<author>
			<persName><forename type="first">C</forename><surname>Clemmensen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2017.01.025</idno>
		<ptr target="https://doi.org:10.1016/j.cell.2017.01.025" />
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="758" to="774" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Leptin and the regulation of body weight in mammals</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Halaas</surname></persName>
		</author>
		<idno type="DOI">10.1038/27376</idno>
		<ptr target="https://doi.org:10.1038/27376" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="763" to="770" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Funcke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Scherer</surname></persName>
		</author>
		<idno type="DOI">10.1194/jlr.R094060</idno>
		<ptr target="https://doi.org:10.1194/jlr.R094060" />
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1648" to="1684" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The role of hepatokines in metabolism</title>
		<author>
			<persName><forename type="first">N</forename><surname>Stefan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Häring</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrendo.2012.258</idno>
		<ptr target="https://doi.org:10.1038/nrendo.2012.258" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="144" to="152" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">An evolutionary perspective on immunometabolism</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Luan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Medzhitov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page">3932</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Exerkines in health, resilience and disease</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Chow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Endocrinology</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="273" to="289" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Docherty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Sports Science, Medicine and Rehabilitation</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">5</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Fundamental constraints to the logic of living systems</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sole</surname></persName>
		</author>
		<idno type="DOI">10.1098/rsfs.2024.0010</idno>
		<ptr target="https://doi.org:10.1098/rsfs.2024.0010" />
	</analytic>
	<monogr>
		<title level="j">Interface Focus</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">20240010</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Physical Constraints in Intracellular Signaling: The Cost of Sending a Bit</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Bryant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Machta</surname></persName>
		</author>
		<idno type="DOI">10.1103/PhysRevLett.131.068401</idno>
		<ptr target="https://doi.org:10.1103/PhysRevLett.131.068401" />
	</analytic>
	<monogr>
		<title level="j">Phys Rev Lett</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page">68401</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Physical bioenergetics: Energy fluxes, budgets, and constraints in cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.2026786118</idno>
		<ptr target="https://doi.org:10.1073/pnas.2026786118" />
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Balancing growth, reproduction, maintenance, and activity in evolved energy economies</title>
		<author>
			<persName><forename type="first">H</forename><surname>Pontzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mcgrosky</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cub.2022.05.018</idno>
		<ptr target="https://doi.org:10.1016/j.cub.2022.05.018" />
	</analytic>
	<monogr>
		<title level="j">Curr Biol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="709" to="R719" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Daily energy expenditure through the human life course</title>
		<author>
			<persName><forename type="first">H</forename><surname>Pontzer</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.abe5017</idno>
		<ptr target="https://doi.org:10.1126/science.abe5017" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="808" to="812" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Cellular allostatic load is linked to increased energy expenditure and accelerated biological aging</title>
		<author>
			<persName><forename type="first">N</forename><surname>Bobba-Alves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page">106322</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The energetic cost of allostasis and allostatic load</title>
		<author>
			<persName><forename type="first">N</forename><surname>Bobba-Alves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R.-P</forename><surname>Juster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2022.105951</idno>
		<ptr target="https://doi.org:10.1016/j.psyneuen.2022.105951" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page">105951</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases</title>
		<author>
			<persName><forename type="first">G</forename><surname>Sturm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Communications biology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">22</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Hypermetabolism and energetic constraints in mitochondrial disorders</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Sercel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Metabolism</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="192" to="195" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The brain-body energy conservation model of aging</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Shaulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Aging</title>
		<imprint>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The physical frailty syndrome as a transition from homeostatic symphony to cacophony</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Fried</surname></persName>
		</author>
		<idno type="DOI">10.1038/s43587-020-00017-z</idno>
		<ptr target="https://doi.org:10.1038/s43587-020-00017-z" />
	</analytic>
	<monogr>
		<title level="j">Nat Aging</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="36" to="46" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Mitochondrial signal transduction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S</forename><surname>Shirihai</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2022.10.008</idno>
		<ptr target="https://doi.org:10.1016/j.cmet.2022.10.008" />
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1620" to="1653" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Finkel</surname></persName>
		</author>
		<author>
			<persName><surname>Mitohormesis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2023.10.011</idno>
		<ptr target="https://doi.org:10.1016/j.cmet.2023.10.011" />
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1872" to="1886" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Mitochondrial DNA: cellular genotoxic stress sentinel</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Sainz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Shadel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tibs.2021.05.004</idno>
		<ptr target="https://doi.org:10.1016/j.tibs.2021.05.004" />
	</analytic>
	<monogr>
		<title level="j">Trends Biochem Sci</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Mitochondrial-derived peptides in energy metabolism</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Merry</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpendo.00249.2020</idno>
		<ptr target="https://doi.org:10.1152/ajpendo.00249.2020" />
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">319</biblScope>
			<biblScope unit="page" from="659" to="E666" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Inter-tissue communication of mitochondrial stress and metabolic health</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1093/lifemeta/load001</idno>
		<ptr target="https://doi.org:10.1093/lifemeta/load001" />
	</analytic>
	<monogr>
		<title level="j">Life Metab</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The power and potential of mitochondria transfer</title>
		<author>
			<persName><forename type="first">N</forename><surname>Borcherding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Brestoff</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41586-023-06537-z</idno>
		<ptr target="https://doi.org:10.1038/s41586-023-06537-z" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">623</biblScope>
			<biblScope unit="page" from="283" to="291" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">GDF15: a hormone conveying somatic distress to the brain</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Lockhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Saudek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>O'rahilly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrine reviews</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The energetics of cellular life transitions</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Monzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life metabolism</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">51</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Plasma proteomic signature of age in healthy humans</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tanaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aging cell</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">12799</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Undulating changes in human plasma proteome profiles across the lifespan</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lehallier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1843" to="1850" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Systematic review and analysis of human proteomics aging studies unveils a novel proteomic aging clock and identifies key processes that change with age</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Shokhirev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wyss-Coray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lehallier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ageing research reviews</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page">101070</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Atlas of the plasma proteome in health and disease in 53,026 adults</title>
		<author>
			<persName><forename type="first">Y.-T</forename><surname>Deng</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2024.10.045</idno>
		<ptr target="https://doi.org:10.1016/j.cell.2024.10.045" />
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Blood protein assessment of leading incident diseases and mortality in the UK Biobank</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Gadd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Aging</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="939" to="948" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">GDF15 linked to maternal risk of nausea and vomiting during pregnancy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fejzo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">625</biblScope>
			<biblScope unit="page" from="760" to="767" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Role of growth differentiation factor 15 in cancer cachexia (Review)</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ma</surname></persName>
		</author>
		<idno type="DOI">10.3892/ol.2023.14049</idno>
		<ptr target="https://doi.org:10.3892/ol.2023.14049" />
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">462</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Klein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature communications</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">1041</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">GDF15 plasma level is inversely associated with level of physical activity and correlates with markers of inflammation and muscle weakness</title>
		<author>
			<persName><forename type="first">M</forename><surname>Conte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in immunology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">915</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sharma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Investigation</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.3389/fped.2022.851534</idno>
		<ptr target="https://doi.org:10.3389/fped.2022.851534" />
	</analytic>
	<monogr>
		<title level="j">Front Pediatr</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">851534</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: A meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<idno type="DOI">10.1002/acn3.51104</idno>
		<ptr target="https://doi.org:10.1002/acn3.51104" />
	</analytic>
	<monogr>
		<title level="j">Ann Clin Transl Neurol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1204" to="1213" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Mitochondrial synapses: intracellular communication and signal integration</title>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends in neurosciences</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="468" to="474" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Collective intelligence: A unifying concept for integrating biology across scales and substrates</title>
		<author>
			<persName><forename type="first">P</forename><surname>Mcmillen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Communications Biology</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">378</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Biomolecular computing systems: principles, progress and potential</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Benenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Genetics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="455" to="468" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">GDF15 is a dynamic biomarker of the integrated stress response in the central nervous system</title>
		<author>
			<persName><forename type="first">J</forename><surname>Asundi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CNS Neuroscience &amp; Therapeutics</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page">14600</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Worth</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.55164</idno>
		<ptr target="https://doi.org:10.7554/eLife.55164" />
	</analytic>
	<monogr>
		<title level="j">Elife</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Activation of GFRAL+ neurons induces hypothermia and glucoregulatory responses associated with nausea and torpor</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Ruud</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Reports</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15</title>
		<author>
			<persName><forename type="first">J.-Y</forename><surname>Hsu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">550</biblScope>
			<biblScope unit="page" from="255" to="259" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Mullican</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1150" to="1157" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Emmerson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1215" to="1219" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature medicine</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1158" to="1166" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Sensory circumventricular organs: central roles in integrated autonomic regulation</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Cottrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Ferguson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Regulatory peptides</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="11" to="23" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">The circumventricular organs: an atlas of comparative anatomy and vascularization</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Duvernoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Risold</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainresrev.2007.06.002</idno>
		<ptr target="https://doi.org:10.1016/j.brainresrev.2007.06.002" />
	</analytic>
	<monogr>
		<title level="j">Brain Res Rev</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="119" to="147" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Origin and physiological roles of inflammation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Medzhitov</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature07201</idno>
		<ptr target="https://doi.org:10.1038/nature07201" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">454</biblScope>
			<biblScope unit="page" from="428" to="435" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">The mitochondrial disease biomarker GDF15 is quantifiable in saliva, exhibits dynamic properties, and correlates with disease severity</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ymgme.2025.109179</idno>
		<ptr target="https://doi.org/10.1016/j.ymgme.2025.109179" />
	</analytic>
	<monogr>
		<title level="j">Molecular Genetics and Metabolism</title>
		<imprint>
			<biblScope unit="page">109179</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">The genotype-tissue expression (GTEx) project</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lonsdale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature genetics</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="580" to="585" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Tissue-based map of the human proteome</title>
		<author>
			<persName><forename type="first">M</forename><surname>Uhlén</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page">1260419</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">NADH reductive stress drives metabolic reprogramming</title>
		<author>
			<persName><forename type="first">R</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tcb.2025.07.005</idno>
		<ptr target="https://doi.org:10.1016/j.tcb.2025.07.005" />
	</analytic>
	<monogr>
		<title level="j">Trends Cell Biol</title>
		<imprint>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">IL-6 in inflammation, immunity, and disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Narazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kishimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cold Spring Harbor perspectives in biology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">16295</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Systemic effects of mitochondrial stress</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bar-Ziv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dillin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO reports</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">50094</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Blood biomarkers of mitochondrial disease-One for all or all for one?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Suomalainen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Handbook of Clinical Neurology</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="page" from="251" to="257" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">The GDF15-GFRAL pathway in health and metabolic disease: friend or foe?</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Breit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annual review of physiology</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="127" to="151" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Metabolic Messenger: growth differentiation factor 15</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Breit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Tsai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Metabolism</title>
		<imprint>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">elife</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">49178</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">A genetically encoded tool to increase cellular NADH/NAD+ ratio in living cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Pan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature chemical biology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="594" to="604" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">The Energy Resistance Principle</title>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Murugan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<date type="published" when="2025">2025</date>
			<publisher>In Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Mitochondrial dysfunction and lipid accumulation in the human diaphragm during mechanical ventilation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American journal of respiratory and critical care medicine</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="1140" to="1149" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">The energetics of cellular life transitions</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Monzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<idno type="DOI">10.1093/lifemeta/load051</idno>
		<ptr target="https://doi.org:10.1093/lifemeta/load051" />
	</analytic>
	<monogr>
		<title level="j">Life Metab</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">The integrated stress response: From mechanism to disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Costa-Mattioli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page">5314</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Integrated stress response regulates GDF15 secretion from adipocytes, preferentially suppresses appetite for a high-fat diet and improves obesity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Miyake</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Iscience</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway</title>
		<author>
			<persName><forename type="first">X</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">579</biblScope>
			<biblScope unit="page" from="427" to="432" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">AMPK mediates energetic stress-induced liver GDF15</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Townsend</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The FASEB Journal</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page">21218</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Fibroblast growth factor 21 drives dynamics of local and systemic stress responses in mitochondrial myopathy with mtDNA deletions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Forsström</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell metabolism</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page">1047</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Mitochondrial and Stress-Related Psychobiological Regulation of FGF21 in Humans</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kurade</surname></persName>
		</author>
		<idno>2001. 2030.25321437</idno>
	</analytic>
	<monogr>
		<title level="j">medRxiv</title>
		<imprint>
			<date type="published" when="2025">2025. 2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Adaptation to mitochondrial stress requires CHOP-directed tuning of ISR</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kaspar</surname></persName>
		</author>
		<idno type="DOI">10.1126/sciadv.abf0971</idno>
		<ptr target="https://doi.org:10.1126/sciadv.abf0971" />
	</analytic>
	<monogr>
		<title level="j">Sci Adv</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Quirós</surname></persName>
		</author>
		<idno type="DOI">10.1083/jcb.201702058</idno>
		<ptr target="https://doi.org:10.1083/jcb.201702058" />
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="2027" to="2045" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Stress-induced FGF21 and GDF15 in obesity and obesity resistance</title>
		<author>
			<persName><forename type="first">S</forename><surname>Keipert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ost</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends in Endocrinology &amp; Metabolism</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="904" to="915" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Growthdifferentiation-factor 15 levels in obese and healthy pregnancies: relation to insulin resistance and insulin secretory function</title>
		<author>
			<persName><forename type="first">U</forename><surname>Andersson-Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Joelsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Svedin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mallard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Holmäng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Endocrinology</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="92" to="100" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Systematic review and analysis of human proteomics aging studies unveils a novel proteomic aging clock and identifies key processes that change with age</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Shokhirev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wyss-Coray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lehallier</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.arr.2020.101070</idno>
		<ptr target="https://doi.org:10.1016/j.arr.2020.101070" />
	</analytic>
	<monogr>
		<title level="j">Ageing Res Rev</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page">101070</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Plasma proteomic signature of age in healthy humans</title>
		<author>
			<persName><forename type="first">T</forename><surname>Tanaka</surname></persName>
		</author>
		<idno type="DOI">10.1111/acel.12799</idno>
		<ptr target="https://doi.org:10.1111/acel.12799" />
	</analytic>
	<monogr>
		<title level="j">Aging Cell</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">12799</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ost</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO reports</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">48804</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Mitochondrial stress-induced GDF15-GFRAL axis promotes anxiety-like behavior and CRH-dependent anorexia</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Gil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<biblScope unit="page">461199</biblScope>
			<date type="published" when="2009">2021. 2009. 2022. 2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">133362</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">The Energetic Stress Marker GDF15 is Induced by Acute Psychosocial Stress</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1101/2024.04.19.590241</idno>
		<ptr target="https://doi.org:10.1101/2024.04.19.590241" />
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Lyu</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11239-024-03019-5</idno>
		<ptr target="https://doi.org:10.1007/s11239-024-03019-5" />
	</analytic>
	<monogr>
		<title level="j">J Thromb Thrombolysis</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1109" to="1121" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Role and Mechanism of Growth Differentiation Factor 15 in Chronic Kidney Disease</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Tang</surname></persName>
		</author>
		<idno type="DOI">10.2147/jir.S451398</idno>
		<ptr target="https://doi.org:10.2147/jir.S451398" />
	</analytic>
	<monogr>
		<title level="j">J Inflamm Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="2861" to="2871" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Welsh</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0530278100</idno>
		<ptr target="https://doi.org:10.1073/pnas.0530278100" />
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="3410" to="3415" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Prospective Associations of Plasma Growth Differentiation Factor 15 With Physical Performance and Cognitive Functions in Older Adults</title>
		<author>
			<persName><forename type="first">L</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.1093/gerona/glac020</idno>
		<ptr target="https://doi.org:10.1093/gerona/glac020" />
	</analytic>
	<monogr>
		<title level="j">J Gerontol A Biol Sci Med Sci</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="2420" to="2428" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Plasma proteomic profiles predict future dementia in healthy adults</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<idno type="DOI">10.1038/s43587-023-00565-0</idno>
		<ptr target="https://doi.org:10.1038/s43587-023-00565-0" />
	</analytic>
	<monogr>
		<title level="j">Nat Aging</title>
		<imprint>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Growth differentiation factor 15 is increased in stable MS</title>
		<author>
			<persName><forename type="first">A</forename><surname>Amstad</surname></persName>
		</author>
		<idno type="DOI">10.1212/NXI.0000000000000675</idno>
		<ptr target="https://doi.org:10.1212/NXI.0000000000000675" />
	</analytic>
	<monogr>
		<title level="j">Neurol Neuroimmunol Neuroinflamm</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Balancing growth, reproduction, maintenance, and activity in evolved energy economies</title>
		<author>
			<persName><forename type="first">H</forename><surname>Pontzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mcgrosky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Biology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="R709" to="R719" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Reductive stress: The key pathway in metabolic disorders induced by overnutrition</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Advanced Research</title>
		<imprint>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Reductive stress-a common metabolic feature of obesity and cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ye</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.apsb.2024.08.034100</idno>
		<ptr target="https://doi.org:10.1016/j.apsb.2024.08.034100" />
	</analytic>
	<monogr>
		<title level="j">Acta Pharm Sin B</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="5181" to="5185" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15</title>
		<author>
			<persName><forename type="first">I</forename><surname>Cimino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">GDF15 mediates the effects of metformin on body weight and energy balance</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Coll</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41586-019-1911-y102</idno>
		<ptr target="https://doi.org:10.1038/s41586-019-1911-y102" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">578</biblScope>
			<biblScope unit="page" from="444" to="448" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">An energetic view of stress: Focus on mitochondria</title>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Mcewen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Epel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sandi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in neuroendocrinology</title>
		<imprint>
			<biblScope unit="page">103</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">The human stress response</title>
		<author>
			<persName><forename type="first">G</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lightman</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41574-019-0228-0104</idno>
		<ptr target="https://doi.org:10.1038/s41574-019-0228-0104" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="525" to="534" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Social determinants of health and survival in humans and other animals</title>
		<author>
			<persName><forename type="first">N</forename><surname>Snyder-Mackler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page">105</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Deep rest: An integrative model of how contemplative practices combat stress and enhance the body&apos;s restorative capacity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Crosswell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychological review</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page">106</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Psychobiological regulation of plasma and saliva GDF15 dynamics in health and mitochondrial diseases</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<biblScope unit="page">107</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Biopsychosocial Correlates of Resting and Stress-Reactive Salivary GDF15: Preliminary Findings</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trumpff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R.-P</forename><surname>Juster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<idno type="DOI">10.1101/2025.02.27.640377108</idno>
		<idno>2025.2002.2027.640377</idno>
		<ptr target="https://doi.org:10.1101/2025.02.27.640377108" />
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">GDF15 links adipose tissue lipolysis with anxiety</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Townsend</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Metabolism</title>
		<imprint>
			<biblScope unit="page">109</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Impact of acute stress on murine metabolomics and metabolic flux</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page">110</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Metabolic features of treatment-refractory major depressive disorder with suicidal ideation</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Pan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Translational psychiatry</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">111</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Frye</surname></persName>
		</author>
		<idno type="DOI">10.1038/tp.2015.185112</idno>
		<ptr target="https://doi.org:10.1038/tp.2015.185112" />
	</analytic>
	<monogr>
		<title level="j">Transl Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">689</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Late-life depression is associated with increased levels of GDF-15, a pro-aging mitokine</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mastrobattista</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Geriatric Psychiatry</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">113</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Plasma GDF15 level is elevated in psychosis and inversely correlated with severity</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific reports</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">114</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Further evidence of accelerated aging in bipolar disorder: focus on GDF-15</title>
		<author>
			<persName><forename type="first">F</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Translational neuroscience</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">115</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: a metaanalysis of mean differences and variability</title>
		<author>
			<persName><forename type="first">M</forename><surname>Solmi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain, Behavior, and Immunity</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page">116</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder</title>
		<author>
			<persName><forename type="first">R</forename><surname>Haapakoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mathieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Ebmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Alenius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kivimäki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain, behavior, and immunity</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page">117</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">A meta-analysis of cytokines in major depression</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Dowlati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biological psychiatry</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page">118</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Association between GDF15, poverty and mortality in urban middle-aged African American and white adults</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Freeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plos one</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">119</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Shafi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page">120</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality</title>
		<author>
			<persName><forename type="first">C</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Human Behaviour</title>
		<imprint>
			<biblScope unit="page">121</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Exercise as Mitochondrial Medicine: How Does the Exercise Prescription Affect Mitochondrial Adaptations to Training?</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev-physiol-022724-104836122</idno>
		<ptr target="https://doi.org:10.1146/annurev-physiol-022724-104836122" />
	</analytic>
	<monogr>
		<title level="j">Annu Rev Physiol</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="107" to="129" />
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">The association between serum growth differentiation factor-15 and 3-month depression after acute ischemic stroke</title>
		<author>
			<persName><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Affective Disorders</title>
		<imprint>
			<biblScope unit="volume">260</biblScope>
			<biblScope unit="page">123</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Serum growth differentiation factor 15 levels are associated with depression after ischemic stroke</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Heart Association</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">124</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Altered circulating GDF-15 level predicts sex hormone imbalance in males with major depressive disorder</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC psychiatry</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">125</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Associations between sex hormones and circulating growth differentiation factor-15 in male patients with major depressive disorder</title>
		<author>
			<persName><forename type="first">T</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Sciences</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">126</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">First behavioural characterisation of a knockout mouse model for the transforming growth factor (TGF)-β superfamily cytokine, MIC-1/GDF15</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Low</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Plos one</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">127</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Optogenetic control of the integrated stress response reveals proportional encoding and the stress memory landscape</title>
		<author>
			<persName><forename type="first">T</forename><surname>Batjargal</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cels.2023.06.001128</idno>
		<ptr target="https://doi.org:10.1016/j.cels.2023.06.001128" />
	</analytic>
	<monogr>
		<title level="j">Cell Syst</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">555</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">The energetics of cellular life transitions</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Monzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<idno type="DOI">10.1093/lifemeta/load051129</idno>
		<ptr target="https://doi.org:10.1093/lifemeta/load051129" />
	</analytic>
	<monogr>
		<title level="j">Life Metabolism</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">The neuroendocrinology of stress: Glucocorticoid signaling mechanisms</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Herman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">The effects of glucocorticoids on adipose tissue lipid metabolism</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Peckett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Riddell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page">131</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Regulation of the hypothalamic-pituitary-adrenocortical stress response</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Herman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Comprehensive physiology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">132</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">GDF15 promotes weight loss by enhancing energy expenditure in muscle</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">619</biblScope>
			<biblScope unit="page">133</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Chung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Cell Biology</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page">134</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of obesity</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page">135</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Fat metabolism during exercise in patients with mitochondrial disease</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Jeppesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Orngreen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Haller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vissing</surname></persName>
		</author>
		<idno type="DOI">10.1001/archneurol.2009.24136</idno>
		<ptr target="https://doi.org:10.1001/archneurol.2009.24136" />
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="365" to="370" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Lactate metabolism during exercise in patients with mitochondrial myopathy</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Jeppesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Orngreen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vissing</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nmd.2013.05.007137</idno>
		<ptr target="https://doi.org:10.1016/j.nmd.2013.05.007137" />
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="629" to="636" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients</title>
		<author>
			<persName><forename type="first">T</forename><surname>Taivassalo</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awg028138</idno>
		<ptr target="https://doi.org:10.1093/brain/awg028138" />
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="413" to="423" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">The brain-body energy conservation model of aging</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Shaulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<idno type="DOI">10.1038/s43587-024-00716-x139</idno>
		<ptr target="https://doi.org:10.1038/s43587-024-00716-x139" />
	</analytic>
	<monogr>
		<title level="j">Nat Aging</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1354" to="1371" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<monogr>
		<title level="m" type="main">Energy Constraints on Human Health</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Kempes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pontzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Behnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Shaulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Picard</surname></persName>
		</author>
		<ptr target="https://osf.io/preprints/osf/ne3qg_v1" />
		<imprint>
			<date type="published" when="2025">2025</date>
			<biblScope unit="page">140</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Mitochondrial origins of the pressure to sleep</title>
		<author>
			<persName><forename type="first">R</forename><surname>Sarnataro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Velasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Monaco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kempf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Miesenböck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">141</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Energy Expenditure in Humans: Principles, Methods, and Changes Throughout the Life Course</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fernández-Verdejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sanchez-Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ravussin</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev-nutr-062122-031443142</idno>
		<ptr target="https://doi.org:10.1146/annurev-nutr-062122-031443142" />
	</analytic>
	<monogr>
		<title level="j">Annu Rev Nutr</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="51" to="76" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">GDF15 induces anorexia through nausea and emesis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Borner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell metabolism</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">143</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist</title>
		<author>
			<persName><forename type="first">O</forename><surname>Benichou</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2022.12.011144</idno>
		<ptr target="https://doi.org:10.1016/j.cmet.2022.12.011144" />
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page">210</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Fatigue in chronic disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Swain</surname></persName>
		</author>
		<idno type="DOI">10.1042/cs0990001145</idno>
		<ptr target="https://doi.org:10.1042/cs0990001145" />
	</analytic>
	<monogr>
		<title level="j">Clinical Science</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Fatigue in patients with chronic disease: results from the populationbased Lifelines Cohort Study</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Goërtz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">146</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">p53-induced GDF-15 expression promotes a pro-regenerative response in human chondrocytes upon cartilage injury</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Marques</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">bioRxiv</title>
		<imprint>
			<biblScope unit="page">147</biblScope>
			<date type="published" when="2004">2024. 2004. 2010. 2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Correlates of fatigue in patients with heart failure</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Evangelista</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Progress in Cardiovascular Nursing</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">148</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Fatigue in patients with chronic heart failure-a burden associated with emotional and symptom distress</title>
		<author>
			<persName><forename type="first">K</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Swedberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ekman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Cardiovascular Nursing</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">149</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Predictors of fatigue in patients with heart failure</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Shieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Chiou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Nursing</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">150</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Fatigue and self-care in patients with chronic heart failure</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kessing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Denollet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Widdershoven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kupper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Cardiovascular Nursing</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">151</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bower</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page">152</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">COPD-related fatigue: a scoping review</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Nursing Research</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page">153</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Psychological coping factors Associated with breast Cancer-related fatigue: a systematic review of recent evidence for stages 0 to III</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schaab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A E</forename><surname>Wijlens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bode</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical breast cancer</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">154</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">A study on improving cancer-related fatigue and disease-related psychological variables in patients with cervical cancer based on online mindfulness-based stress reduction: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ouyang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Women&apos;s Health</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">155</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Promoting salutogenic pathways to health through complementary and integrative health approaches</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Quinlan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Psychology</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">156</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page">157</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">Identification of Potential Blood-Based Biomarkers for Frailty by Using an Integrative Approach</title>
		<author>
			<persName><forename type="first">M</forename><surname>Suganuma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gerontology</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page">158</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Associations of circulating GDF15 with combined cognitive frailty and depression in older adults of the MARK-AGE study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Kochlik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">GeroScience</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page">159</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Association between a Mediterranean lifestyle and growth differentiation factor 15: the seniors ENRICA-2 cohort</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sotos-Prieto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radical Biology and Medicine</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page">160</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Frailty, psychological well-being, and social isolation in older adults with cognitive impairment during the SARS-CoV-2 pandemic: data from the GeroCovid initiative</title>
		<author>
			<persName><forename type="first">C</forename><surname>Terziotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychogeriatrics</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">161</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Does cumulative psychosocial stress explain frailty disparities in community-dwelling older adults?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shakya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Mcconnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Cary</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Archives of Gerontology and Geriatrics</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page">162</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Deletion of Gdf15 Reduces ER Stress-induced Beta-cell Apoptosis and Diabetes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1210/endocr/bqac030163</idno>
		<ptr target="https://doi.org:10.1210/endocr/bqac030163" />
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">Muscle endoplasmic reticulum stress in exercise</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Marafon</surname></persName>
		</author>
		<idno type="DOI">10.1111/apha.13799164</idno>
		<ptr target="https://doi.org/10.1111/apha.13799164" />
	</analytic>
	<monogr>
		<title level="j">Acta Physiologica</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page">13799</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Muscle contraction and mitochondrial biogenesis -A brief historical reappraisal</title>
		<author>
			<persName><forename type="first">J</forename><surname>Botella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Motanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Bishop</surname></persName>
		</author>
		<idno type="DOI">10.1111/apha.13813165</idno>
		<ptr target="https://doi.org:10.1111/apha.13813165" />
	</analytic>
	<monogr>
		<title level="j">Acta Physiol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page">13813</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Ponsegromab for the treatment of cancer cachexia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Groarke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<imprint>
			<biblScope unit="page">166</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15</title>
		<author>
			<persName><forename type="first">T</forename><surname>Borner</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcsm.12169167</idno>
		<ptr target="https://doi.org:10.1002/jcsm.12169167" />
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="417" to="427" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Impact of physical activity on physical function, mitochondrial energetics, ROS production, and Ca2+ handling across the adult lifespan in men</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cefis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Reports Medicine</title>
		<imprint>
			<biblScope unit="page">168</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">Mitochondrial and metabolic features of salugenesis and the healing cycle</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Naviaux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mitochondrion</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page">169</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Hypothalamic glucose-sensing mechanisms</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Diano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page">170</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Sensory circumventricular organs, neuroendocrine control, and metabolic regulation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Dow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Young</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolites</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">171</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Glial cells as integrators of peripheral and central signals in the regulation of energy homeostasis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nampoothiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nogueiras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schwaninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Prevot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature metabolism</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">172</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">Mechanisms and consequences of oxygen and carbon dioxide sensing in mammals</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Cummins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Strowitzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Taylor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiological reviews</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page">173</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Describing the Weight-Reduced State: Physiology, Behavior, and Interventions</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Aronne</surname></persName>
		</author>
		<idno type="DOI">10.1002/oby.23086174</idno>
		<ptr target="https://doi.org:10.1002/oby.23086174" />
	</analytic>
	<monogr>
		<title level="j">Obesity (Silver Spring)</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">Suppl 1</biblScope>
			<biblScope unit="page" from="9" to="24" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">A global reference for human genetic variation</title>
		<author>
			<persName><forename type="first">C</forename></persName>
			<affiliation>
				<orgName type="collaboration">Genomes Project</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1038/nature15393175</idno>
		<ptr target="https://doi.org:10.1038/nature15393175" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">526</biblScope>
			<biblScope unit="page" from="68" to="74" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Karusheva</surname></persName>
		</author>
		<idno type="DOI">10.1093/jalm/jfac055176</idno>
		<ptr target="https://doi.org:10.1093/jalm/jfac055176" />
	</analytic>
	<monogr>
		<title level="j">J Appl Lab Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1388" to="1400" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Identification and characterization of human GDF15 knockouts</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gurtan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Metabolism</title>
		<imprint>
			<biblScope unit="page">177</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">Long-acting MIC-1/GDF15 molecules to treat obesity: evidence from mice to monkeys</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xiong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science translational medicine</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">178</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">A Growth Differentiation Factor 15 Receptor Agonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page">179</biblScope>
			<date type="published" when="2025">2025</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Fatigue and mental status of caregivers of severely chronically ill patients</title>
		<author>
			<persName><forename type="first">S.-G</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pain Research and Management</title>
		<imprint>
			<biblScope unit="page">180</biblScope>
			<date type="published" when="2020">2020. 2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">The impact of job demands and workload on stress and fatigue</title>
		<author>
			<persName><forename type="first">W</forename><surname>Macdonald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Australian psychologist</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page">181</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main">The association of fatigue with dispositional mindfulness: relationships by levels of depressive symptoms, sleep quality, childhood adversity, and chronic medical conditions</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Whitaker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Preventive Medicine</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page">182</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">Exploring Risk Perception, Mental Health, Mental Fatigue, Stigma, and the Quality of Life among UAE Healthcare Workers during the COVID-19 Pandemic: A National Multicentric Cross-Sectional Study</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Aljawarneh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Environmental Research and Public Health</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">183</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<monogr>
		<author>
			<persName><forename type="first">S</forename><surname>Shakya</surname></persName>
		</author>
		<title level="m">Structural, Biological, and Psychosocial Determinants of Frailty in Community-Dwelling Older Adults in the US</title>
		<imprint>
			<date type="published" when="2023">2023</date>
			<biblScope unit="page">184</biblScope>
		</imprint>
		<respStmt>
			<orgName>Duke University</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">Burnout, moral distress, and compassion fatigue as correlates of posttraumatic stress symptoms in clinical and nonclinical healthcare workers</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Boitet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Healthcare Management</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page">185</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Perceived stress, fatigue symptoms, and posttraumatic stress disorder symptoms among young adult college students</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kalmakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Alhowaymel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Chiodo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Child and Adolescent Psychiatric Nursing</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page">186</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">The association between academic stress, social support, and selfregulatory fatigue among nursing students: a cross-sectional study based on a structural equation modelling approach</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Yuhuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC medical education</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">187</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main">Bedtime procrastination related to loneliness among Chinese university students during post-pandemic period: a moderated chain mediation model</title>
		<author>
			<persName><forename type="first">C</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">188</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Loneliness and sleep in everyday life: Using ecological momentary assessment to characterize the shape of daily loneliness experience</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Zawadzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sleep Health</title>
		<imprint>
			<biblScope unit="page">189</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<analytic>
		<title level="a" type="main">Depression, Anxiety, Energy, and Fatigue Among Nurses Who Cared for Patients During the COVID-19 Pandemic: A Cross-Sectional Study</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Soylu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Holistic Nursing</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">190</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b189">
	<analytic>
		<title level="a" type="main">Resilience during uncertainty? Greater social connectedness during COVID-19 lockdown is associated with reduced distress and fatigue</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Nitschke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British journal of health psychology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">191</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">Effects of mind-body exercise on perimenopausal and postmenopausal women: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Menopause</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">192</biblScope>
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<analytic>
		<title level="a" type="main">Relationship between personality measures and perceived mental fatigability</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Allen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of aging and health</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="750" to="760" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
